ORBIMED ADVISORS LLC Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$5.5T
Holdings
112
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (112 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | NXTCNEXTCURE INC | 1,141,200 | $2.5B | 0.05% | |
| 102 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 1,541,000 | $2.2B | 0.04% | |
| 103 | PHGEBIOMX INC | 4,517,589 | $2.0B | 0.04% | |
| 104 | CMMBCHEMOMAB THERAPEUTICS LTD | 2,241,274 | $1.7B | 0.03% | |
| 105 | KZRKEZAR LIFE SCIENCES INC | 1,927,000 | $1.7B | 0.03% | |
| 106 | VIGLVIGIL NEUROSCIENCE INC | 448,891 | $1.5B | 0.03% | |
| 107 | DVAXDYNAVAX TECHNOLOGIES CORP | 113,500 | $1.4B | 0.03% | |
| 108 | CALCCALCIMEDICA INC | 297,380 | $1.2B | 0.02% | |
| 109 | —YS BIOPHARMA CO LTD | 1,534,430 | $1.1B | 0.02% | |
| 110 | AFIBACUTUS MED INC | 2,648,386 | $497.9M | 0.01% | |
| 111 | LYELLYELL IMMUNOPHARMA INC | 199,500 | $444.9M | 0.01% | |
| 112 | —SINGULAR GENOMICS SYSTEMS IN | 540,697 | $278.0M | 0.01% | |
| 113 | XERSXERIS BIOPHARMA HOLDINGS INC | 80,420 | $177.7M | 0.00% |
PreviousPage 2 of 2